You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Pk/pd evaluation of protein binding of ceftriaxone and levofloxacin in seriously ill patients
- At: Glasgow (Scotland) (2018)
- Type: Poster
- Poster code: POS-PAA-012
- By: SCOULAR, Sarah (University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Clinical Pharmacy)
- Co-author(s): Sarah Scoular: Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, United States
Ashley Hall
Sanjana Rao: University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, ;, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, United States
Scott Mueller: Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, United States
Ty Kiser: Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, United States
Doug Fish: Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, United States - Abstract:
Background
Protein deficiency in seriously ill patients may lead to increased unbound serum concentrations of highly protein bound antibiotics potentially leading to improved clinical outcomes.
Methods
Patients ≥18 years of age with creatinine clearance ≥50 ml/minute were prospectively enrolled into PK studies of ceftriaxone (CRO) and levofloxacin.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026